未知生产厂商
Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II.
Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II.
Dutogliptin is a potent and selective inhibitor of DPP4, a serine protease that has emerged as an important target for the treatment of type 2 diabetes. Inhibiting DPP4 increases the physiological levels of regulatory peptides, such as GLP-1, an important modulator of insulin response and digestion.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
